Resultados da pesquisa - Mathias Toft
- A mostrar 1 - 20 resultados de 41
- Go to Next Page
-
1
-
2
-
3
Long-term follow-up of thalamic deep brain stimulation for essential tremor – patient satisfaction and mortality Por Mari Naumann Børretzen, Silje Bjerknes, Terje Sæhle, Mona Skjelland, Inger Marie Skogseid, Mathias Toft, Espen Dietrichs
Publicado em 2014Artigo -
4
-
5
Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia Por Zafar Iqbal, Siri Lynne Rydning, Iselin Marie Wedding, Jeanette Koht, Lasse Pihlstrøm, Aina Rengmark, Sandra Pilar Henriksen, Chantal Tallaksen, Mathias Toft
Publicado em 2017Artigo -
6
Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes Por Chiara Cappelletti, Sandra Pilar Henriksen, Hanneke Geut, Annemieke J.M. Rozemüller, Wilma D.J. van de Berg, Lasse Pihlstrøm, Mathias Toft
Publicado em 2023Artigo -
7
-
8
APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease Por Jon-Anders Tunold, Hanneke Geut, Annemieke J.M. Rozemüller, Sandra Pilar Henriksen, Mathias Toft, Wilma D.J. van de Berg, Lasse Pihlstrøm
Publicado em 2021Artigo -
9
-
10
Personality Changes after Deep Brain Stimulation in Parkinson’s Disease Por Uyen Pham, Anne‐Kristin Solbakk, Inger-Marie Skogseid, Mathias Toft, Are Hugo Pripp, Ane Konglund, Stein Andersson, Ira Haraldsen, Dag Aarsland, Espen Dietrichs, Ulrik Fredrik Malt
Publicado em 2015Artigo -
11
Fine mapping and resequencing of the PARK16 locus in Parkinson’s disease Por Lasse Pihlstrøm, Aina Rengmark, Kari Anne Bjørnarå, Nil Dizdar, Camilla Fardell, Lars Forsgren, Björn Holmberg, Jan Larsen, Jan Linder, Hans Nissbrandt, Ole‐Bjørn Tysnes, Espen Dietrichs, Mathias Toft
Publicado em 2015Artigo -
12
Prehospital screening of acute stroke with the National Institutes of Health Stroke Scale (ParaNASPP): a stepped-wedge, cluster-randomised controlled trial Por Mona Guterud, Helge Fagerheim Bugge, Jo R⊘islien, Jo Kramer‐Johansen, Mathias Toft, Hege Ihle‐Hansen, Kristi G. Bache, Karianne Larsen, Anne‐Cathrine Braarud, Else Charlotte Sandset, Maren Ranhoff Hov
Publicado em 2023Artigo -
13
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease Por Lasse Pihlstrøm, Gunnar Axelsson, Kari Anne Bjørnarå, Nil Dizdar, Camilla Fardell, Lars Forsgren, Björn Holmberg, Jan Larsen, Jan Linder, Hans Nissbrandt, Ole‐Bjørn Tysnes, E. Wallin Öhman, Espen Dietrichs, Mathias Toft
Publicado em 2012Artigo -
14
A comprehensive analysis of <i>SNCA</i>‐related genetic risk in sporadic parkinson disease Por Lasse Pihlstrøm, Cornelis Blauwendraat, Chiara Cappelletti, Victoria Berge‐Seidl, Margrete Langmyhr, Sandra Pilar Henriksen, Wilma D.J. van de Berg, J. Raphael Gibbs, Mark Cookson, Andrew Singleton, Mike A. Nalls, Mathias Toft
Publicado em 2018Artigo -
15
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease Por Sara C. Staubo, Ole‐Martin Fuskevåg, Mathias Toft, Ingeborg Haugesag Lie, Kirsti M. J. Alvik, Pål Jostad, Stein H. Tingvoll, Hallvard Lilleng, Kristina Rosqvist, Elisabet Størset, Per Odin, Espen Dietrichs, Erik Sveberg Dietrichs
Publicado em 2025Artigo -
16
Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology Por Lasse Pihlstrøm, Gemma Shireby, Hanneke Geut, Sandra Pilar Henriksen, Annemieke J.M. Rozemüller, Jon‐Anders Tunold, Eilís Hannon, Paul T. Francis, Alan Thomas, Seth Love, Jonathan Mill, Wilma D.J. van de Berg, Mathias Toft
Publicado em 2022Revisão -
17
Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations Por Jennifer M. Kachergus, Ignácio F. Mata, Mary Hulihan, Julie P. Taylor, Sarah Lincoln, Jan Aasly, Jonathan Gibson, Owen A. Ross, Timothy Lynch, Joseph Wiley, Haydeh Payami, John G. Nutt, Demetrius M. Maraganore, K Czyźewski, Maria Styczyńska, Zbigniew K. Wszołek, Matthew J. Farrer, Mathias Toft
Publicado em 2005Artigo -
18
Fine mapping of the HLA locus in Parkinson’s disease in Europeans Por Eric Yu, Aditya Ambati, Maren Stolp Andersen, Lynne Krohn, Mehrdad A. Estiar, Prabhjyot Saini, Konstantin Senkevich, Yuri L. Sosero, Ashwin Ashok Kumar Sreelatha, Jennifer A. Ruskey, Farnaz Asayesh, Dan Spiegelman, Mathias Toft, Marte K. Viken, Manu Sharma, Cornelis Blauwendraat, Lasse Pihlstrøm, Emmanuel Mignot, Ziv Gan‐Or
Publicado em 2021Artigo -
19
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease Por Jon‐Anders Tunold, Manuela Tan, Shunsuke Koga, Hanneke Geut, Annemieke J.M. Rozemüller, Rebecca R. Valentino, Hiroaki Sekiya, Nicholas B. Martin, Michael G. Heckman, José Brás, Rita Guerreiro, Dennis W. Dickson, Mathias Toft, Wilma D.J. van de Berg, Owen A. Ross, Lasse Pihlstrøm
Publicado em 2023Artigo -
20
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease Por Jan Aasly, Carles Vilariño‐Güell, Justus C. Dächsel, Philip J. Webber, Andrew B. West, Kristoffer Haugarvoll, Krisztina K. Johansen, Mathias Toft, John G. Nutt, Haydeh Payami, Jennifer M. Kachergus, Sarah Lincoln, Amela Felic, Christian Wider, Alexandra I. Soto‐Ortolaza, Stephanie A. Cobb, Linda R. White, Owen A. Ross, Matthew J. Farrer
Publicado em 2010Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Disease
Biology
Genetics
Internal medicine
Gene
Parkinson's disease
Genotype
Single-nucleotide polymorphism
Genetic association
Genome-wide association study
Psychology
Dementia
Allele
Haplotype
LRRK2
Pathology
Locus (genetics)
Odds ratio
Neuroscience
Psychiatry
Linkage disequilibrium
Mutation
Oncology
Bioinformatics
Confidence interval
Dementia with Lewy bodies
Environmental health
Genetic architecture
Genetic variants